Diabetesmidlet Jardiance fra Eli Lilly og Boehringer Ingelheim skal nu også testes som behandling mod nyreskader til patienter både med og uden type 2-diabetes.
Duoen af Eli Lilly og Boehringer Ingelheim har allerede haft stor succes med diabetesmidlet Jardiance (empagliflozin), men nu bliver der skruet op for ambitionerne for midlet.
Mandag kan de to selskaber nemlig meddele, at man sætter gang i studier, hvor midlet skal testes som behandling til patienter med kronisk nyresygdom. Hos patienter med type 2-diabetes, men også til dem uden.
Allerede abonnent? Log Ind.
Associate Director Medical Science – Orphazyme 
QC Manager Drug Substance for Product Supply – Ascendis Pharma 
Supply Chain Manager - Y-mAbs Therapeutics Manager of Medical Writing - Orphazyme 
Senior Cost Accountant - Zealand Pharma 
Senior CMC Specialist, Analytical - Genmab 
CMC Project Manager – MC2 Therapeutics 
Medicochef til medicoteknologi i største skala - Region Hovedstaden 
Finance Manager, Syntese Regulatory Affairs Manager – MC2 Therapeutics Senior Accountant - Y-mAbs Therapeutics 
Pharmacovigilance Specialist - Orifarm Director, Alliance Management - Genmab Senior Scientist, Analytical Development - Zealand Pharma 
GCP Auditor / Clinical Quality Manager - ALK Senior Programming Manager - Genmab Senior Medical Writer - Orphazyme 
Sundhedsfaglig chef - Sano Validation and Qualification Chemist for Laboratory Automation Development - ALK Artwork Coordinator - Orifarm Experienced Clinical Project Manager - ALK QC specialist søges - Orifarm Director Pharmacology & New Target Discovery - Y-mAbs Director of Clinical Quality Assurance Operations – Orphazyme 
Erfaren jurist med interesse for lægemiddelområdet - Amgros Senior Manager, Internal Communications - Genmab 
Merck – Director Market Access Associate Director, GMP QA, Commercial Operations - Y-mAbs Therapeutics 
Director CMC, Drug Substance - Galecto 
Experienced Scientist - LEO Pharma Director CMC, Drug Product - Galecto 
Senior Manager Business Development - Ascelia Pharma 
BRIDGE – Translational Excellence Programme: Call for Outstanding Postdocs and Experienced Mentors interested in Translational Medicine Senior Principal IT Business Partner - Genmab 
Nordic General Director, Pharma - MEDICE 
Vice President Global Quality Assurance and Regulatory Affairs – Etac Group 
Er du konsulent med ingeniørbaggrund? - Andreasen & Elmgaard QAA Team Manager - Orifarm 
